A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Adocia
- Target Recruit Count
- 27
- Registration Number
- NCT05373186
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Adocia
- Target Recruit Count
- 30
- Registration Number
- NCT05373199
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Adocia
- Target Recruit Count
- 40
- Registration Number
- NCT05373212
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Adocia
- Target Recruit Count
- 80
- Registration Number
- NCT04816890
- Locations
- 🇩🇪
Profil Mainz GmbH & Co, Mainz, Germany
🇩🇪Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Adocia
- Target Recruit Count
- 32
- Registration Number
- NCT04501107
- Locations
- 🇩🇪
Profil GmbH, Mainz, Germany
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Adocia
- Target Recruit Count
- 44
- Registration Number
- NCT03981627
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Adocia
- Target Recruit Count
- 24
- Registration Number
- NCT03916640
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Adocia
- Target Recruit Count
- 24
- Registration Number
- NCT03512236
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Adocia
- Target Recruit Count
- 32
- Registration Number
- NCT03180710
- Locations
- 🇩🇪
Profil Mainz GmbH & Co. KG, Mainz, Germany
🇩🇪Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-07
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Adocia
- Target Recruit Count
- 43
- Registration Number
- NCT03179332
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
© Copyright 2024. All Rights Reserved by MedPath